RxSight Ophthalmic (RXST) Long-Term Liabilities to Equity

Corporate emblem and logo of RxSight Ophthalmic (RXST)

RxSight, Inc. (RXST) management is demonstrating brilliant strategic execution, effectively increasing profitability and sales volumes. The company has established a premium brand image through unique vision correction lenses that are highly valued by surgeons. This price chart with the 0.03 indicator links these successes to the business's resilience. Demand for ophthalmological services remains independent of economic conditions and is growing steadily due to demographic trends.

RXST RxSight Corp: Long-Term Debt to Capital in the range 07/04/2022 - 10/29/2026
Manufactured product of RxSight, Inc.

This ratio determines the degree of dependence of long-term financial stability on borrowed funds by comparing credit obligations exceeding one year with the net asset value. Analyzing the dynamics of long-term debt to equity allows for an assessment of the balance between default risk and the investment potential of RxSight, Inc. (RXST) while scaling the production of high-tech AI systems for the precision calibration of intraocular lenses.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital ClearPoint Neuro, Inc.|STXS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STIM|SGHT (Sight Sciences) - Long-Term Debt to Capital|Orchestra BioMed Inc. (OBIO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ANIK|Long-Term Debt to Equity Ratio InspireMD Inc. NSPR|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital